SODIUM ZIRCONIUM CYCLOSILICATE (Lokelma®)
Clinical Indication
Acute hyperkalaemia
Comments
FIRST CHOICE Treatment of acute hyperkalaemia, see local ED pathway.
In line with NICE TA1148
Funding from: 28th July 2026
Date of classification
August 2024
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.